Quarterly Report • Oct 17, 2024
Quarterly Report
Open in ViewerOpens in native device viewer


Celebrating our 40th anniversary with one of the strongest third quarters ever Q3 revenues of NOK 392m (+10%) Q3 diluted EPS of NOK 0.09 (+29%) YTD revenues of NOK 1,305m (+12%) YTD diluted EPS of NOK 0.35 (+35%)
Following the quarter marking the 40th anniversary of our firm, I am very pleased to report one of the strongest third quarters ever. In what is a seasonally slow quarter, we saw robust activity in investment banking transactions and revenues coming close to the NOK 400m mark. This implies 10% growth in the quarter and 12% YTD, lifting our YTD EPS by 35%. This once again demonstrates the leverage of our business model.
The quarter demonstrated the breadth of our franchise, with solid contributions from all products and segments. I would particularly like to highlight our strong performance in Debt Capital Markets (DCM) and the growth in Brokerage and Research.
At the beginning of the year, we initiated a strategic update, reviewing our corporate strategy to ensure it aligns with our long-term objectives. Our mission is to enable companies and capital to grow and perform. This is our top priority as we have the clear ambition to be the obvious choice for clients and top talent in the industry. To enhance our services and increase efficiency, we have strengthened our Nordic integration through clearly defined pan-Nordic product and sector teams and streamlined coordination between sales and research.
While we aim to leverage our current infrastructure and platform, we will continue to invest judiciously in technology and make quality additions to our pool of talent. With such additions, we believe there is significant potential for profitable growth by filling gaps and increasing market share within our current core segments, broadening product offerings, extending market reach and successfully launching new ventures.

Jonas Ström, CEO




2021
2022
2023
2024
1) Nordic primary DCM volumes (NOKbn)


2)





1) Source: Refinitv. Issuers listed on Nordic stock exchanges
2) Source: Stamdate. Corporate high yield, Nordic issuers
3) Source: Mergermarket. Nordic targets, announced transactions with financial advisors. Last quarter estimate reflecting a time-lag in Mergermaket deal registration



| Selected transactions | |||
|---|---|---|---|
| Sale of Kanari to Conscia | Undisclosed | TMT | |
| Sale of Biowater to Uniwater |
Undisclosed | Technology | |
| Sale of Oppdal Skisenter to Alpinco |
Undisclosed | Real Estate | |
| Sale of a majority stake in Permian to Telemos Capital |
Undisclosed | Financials |
Brokerage and Research revenues (NOKm)


Operating costs | Cost increase primarily impacted by profitability-driven compensation model. Continued weakening of NOK inflating fixed cost base

▪ Continued increase in compensation costs (variable) due to our revenue- and profitability-driven compensation model. Average headcount YTD (333) down compared to the first 9 months of last year (343)

Leading full-service supplier operating in the attractive Nordic investment banking market





Increase share of wallet within current core operations and markets

Deliver current and new core services to additional markets and client groups Secure successful launch of new ventures

Keep front staff share >80% Distribution of excess capital
People
Attract, retain and develop top talent

Invest in- and utilise technology to improve offering and efficiency
Brand
Strengthen the ABGSC brand to support and fuel continued growth

Minimum top 3 position across all key products

Increase revenue / head by >20%

Operating margin >25%


"We will outperform and provide best-in-class advice and execution" Dedication
"We work harder, and we are always there for our clients"
"We never give up and can always be trusted to deliver"



| NOKm | Q3 2024 | Q3 2023 | YTD 2024 YTD 2023 | 2023 | |
|---|---|---|---|---|---|
| Corporate Financing | 161.4 | 122.0 | 531.0 | 435.6 | 580.0 |
| M&A and Advisory | 107.3 | 124.9 | 363.0 | 303.2 | 561.8 |
| Brokerage and Research | 123.6 | 109.5 | 411.1 | 422.4 | 565.0 |
| Total revenues | 392.3 | 356.4 | 1,305.2 | 1,161.3 | 1,706.7 |
| Personnel costs | -232.6 | -212.7 | -749.5 | -677.0 | -988.0 |
| Other operating costs | -74.1 | -72.8 | -235.2 | -224.7 | -309.4 |
| Depreciation | -22.0 | -19.5 | -65.1 | -63.9 | -83.9 |
| Total operating costs | -328.7 | -304.9 | -1,049.8 | -965.6 | -1,381.3 |
| Operating profit | 63.7 | 51.5 | 255.4 | 195.7 | 325.4 |
| Net interest | -0.8 | -0.3 | 3.1 | -0.7 | 0.7 |
| Associates | 0.3 | -0.8 | -1.4 | -5.6 | -5.4 |
| Other | -2.6 | 0.4 | -2.8 | -0.3 | -0.8 |
| Net financial result | -3.1 | -0.7 | -1.1 | -6.6 | -5.6 |
| Profit before tax | 59.7 | 50.8 | 253.4 | 189.0 | 319.9 |
| Taxes | -14.8 | -15.5 | -64.1 | -49.7 | -82.5 |
| Net profit | 44.9 | 35.3 | 189.3 | 139.3 | 237.3 |
| Profit / loss to non-controlling interests | -0.2 | 0.6 | -0.4 | 1.2 | 1.0 |
| Profit / loss to owners of the parent | 45.1 | 34.7 | 189.7 | 138.1 | 236.3 |
| NOKm | Q3 2024 | Q3 2023 | YTD 2024 | YTD 2023 | 2023 |
|---|---|---|---|---|---|
| Net profit | 44.9 | 35.3 | 189.3 | 139.3 | 237.3 |
| Items that may be reclassified to profit or loss | |||||
| Exchange differences on translating foreign operations | 10.2 | -10.2 | 21.8 | 24.3 | 22.7 |
| Hedging of investment in foreign operations | -8.8 | 10.5 | -20.8 | -24.9 | -20.7 |
| Income tax relating to items that may be reclassified | 2.2 | -2.6 | 5.2 | 6.2 | 5.2 |
| Total other comprehensive income | 3.5 | -2.3 | 6.2 | 5.6 | 7.2 |
| Total comprehensive income for the period | 48.4 | 33.0 | 195.4 | 144.9 | 244.5 |
| Comprehensive income to non-controlling interests | 0.2 | 0.4 | -0.1 | 1.6 | 1.8 |
| Comprehensive income to owners of the parent | 48.2 | 32.5 | 195.5 | 143.3 | 242.8 |
| Condensed cash flow statement | |||||
|---|---|---|---|---|---|
| NOKm | Q3 2024 | Q3 2023 | YTD 2024 | YTD 2023 | 2023 |
| Cash and cash equivalents - opening balance | 541.7 | 571.4 | 525.7 | 832.0 | 832.0 |
| Net cash flow from operating activities | 168.0 | -9.5 | 147.1 | -107.6 | 140.9 |
| Net cash flow from investing activities | 0.0 | 3.5 | -13.4 | -9.8 | -6.2 |
| Net cash flow from financing activities | -176.5 | 54.3 | -126.2 | -94.8 | -440.9 |
| Net change in cash and cash equivalents | -8.4 | 48.4 | 7.5 | -212.1 | -306.2 |
| Cash and cash equivalents - closing balance | 533.2 | 619.8 | 533.2 | 619.8 | 525.7 |

| NOKm | 30/09/2024 30/09/2023 | 31/12/2023 | |
|---|---|---|---|
| Intangible assets | 163.0 | 174.2 | 158.7 |
| Financial non-current assets | 66.6 | 63.9 | 65.3 |
| Tangible assets | 434.0 | 497.5 | 489.6 |
| Total non-current assets | 663.6 | 735.6 | 713.6 |
| Receivables | 4,756.6 | 3,097.7 | 2,669.7 |
| Investments | 35.8 | 52.6 | 14.2 |
| Cash and bank deposits | 533.2 | 619.8 | 525.7 |
| Total current assets | 5,325.7 | 3,770.1 | 3,209.6 |
| Total assets | 5,989.3 | 4,505.7 | 3,923.2 |
| Paid-in capital | 158.8 | 137.6 | 137.8 |
| Retained earnings | 764.0 | 721.6 | 821.9 |
| Equity attributable to owners of the parent | 922.8 | 859.2 | 959.7 |
| Non controlling interests | 11.6 | 11.6 | 11.7 |
| Total equity | 934.4 | 870.8 | 971.4 |
| Long-term liabilities | 425.8 | 479.4 | 433.3 |
| Short-term interest bearing liabilities | 168.8 | 332.2 | 2.9 |
| Short-term liabilities | 4,460.2 | 2,823.4 | 2,515.6 |
| Total liabilities | 5,054.8 | 3,634.9 | 2,951.8 |
| Total equity and liabilities | 5,989.3 | 4,505.7 | 3,923.2 |
| NOKm | Q3 2024 | Q3 2023 | YTD 2024 | YTD 2023 | 2023 |
|---|---|---|---|---|---|
| Equity attributable to owners of the parent - opening balance | 874.5 | 850.7 | 959.7 | 1,019.1 | 1,019.1 |
| Comprehensive income to owners of the parent | 48.2 | 32.5 | 195.5 | 143.3 | 242.8 |
| Payment to shareholders | 0.0 | 0.0 | -260.3 | -248.7 | -248.7 |
| New issuing of shares | 0.0 | 0.0 | 20.8 | 4.2 | 4.2 |
| Change in own shares | 0.1 | -24.0 | 7.0 | -58.7 | -57.7 |
| Equity attributable to owners of the parent - closing balance | 922.8 | 859.2 | 922.8 | 859.2 | 959.7 |
| Equity attributable to non-controlling interests - opening balance | 11.4 | 11.1 | 11.7 | 7.6 | 7.6 |
| Comprehensive income to non-controlling interests | 0.2 | 0.4 | -0.1 | 1.6 | 1.8 |
| Payment to shareholders | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Business combinations | 0.0 | 0.0 | 0.0 | 2.4 | 2.4 |
| Equity attributable to non-controlling interests - closing balance | 11.6 | 11.6 | 11.6 | 11.6 | 11.7 |
| Total equity - closing balance | 934.4 | 870.8 | 934.4 | 870.8 | 971.4 |
The quarterly report is prepared in accordance with IAS 34 Interim Financial Reporting and International Financial Reporting Standards (IFRS) published by the International Accounting Standards Board (IASB) and all interpretations from the Financial Reporting Interpretations Committee (IFRIC), which have been endorsed by the European Commission for adoption within the EU. The quarterly report is prepared using the same principles as those used for the 2023 annual report. The quarterly report is unaudited.
The preparation of condensed consolidated interim financial statements in accordance with IFRS and the application of the chosen accounting policies require management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on a continuous basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. When preparing these condensed consolidated interim financial statements, the significant judgments made by management in applying the Group's accounting policies and the key sources of estimate uncertainty were the same as those that applied to the consolidated financial statements as of the period ending 31 December 2023.
As described in ABGSC's annual report, ABGSC's total risk exposure is analysed and evaluated at the group level. Risk evaluations are integrated in all business activities both at the group and business unit levels, increasing ABGSC's ability to take advantage of business opportunities. There has not been any significant change in the risk exposure or the risks and uncertainties described in the annual report.
There have not been any changes or transactions with any related parties that significantly impact the Group's financial position or results for the period.
The group segments its business primarily on a product level as this provides the best understanding of the Group's integrated operation. The Group does not allocate profits or split the balance sheet per product. Revenues are also split at an overall geographical level. Segment information is presented on other pages of this report, including on the historical quarterly summary pages.

Compensation Non-Compensation



| Share count | |||||
|---|---|---|---|---|---|
| Figures in thousands |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
| Shares outstanding (period end) |
497 463 , |
497 463 , |
527 735 , |
527 735 , |
527 735 , |
| - Treasury shares (period end) |
9 549 , |
8 649 , |
7 109 , |
7 159 , |
7 059 , |
| + Forward outstanding (period end) contracts |
69 486 , |
68 586 , |
52 999 , |
53 249 , |
53 524 , |
| Diluted shares (period end) |
557 399 , |
557 399 , |
573 624 , |
573 824 , |
574 199 , |
| Shares outstanding (average) |
497 463 , |
497 463 , |
501 163 , |
527 735 , |
527 735 , |
| - Treasury shares (average) |
8 055 , |
8 980 , |
870 7 , |
127 7 , |
125 7 , |
| + Forward outstanding (average) contracts |
69 337 , |
68 916 , |
71 866 , |
53 131 , |
53 532 , |
| Diluted shares (average) |
558 746 , |
557 399 , |
565 159 , |
573 739 , |
574 142 , |
During the quarter, ABGSC sold 800k shares on forward contracts to new partners. ABGSC purchased 425k shares from former partners at an average price of NOK 6.14 per share.
| Shares held by Directors and staff |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
|---|---|---|---|---|---|
| Shares Staff / Shares held by Directors and outstanding |
29% | 29% | 33% | 32% | 30% |
| Shares and fwd held by Directors and Staff / Diluted shares contracts |
38% | 38% | 39% | 38% | 37% |
| Shareholders by (shares outstanding) country |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
|---|---|---|---|---|---|
| Norway | 71% | 72% | 69% | 69% | 69% |
| Great Britain |
5% | 4% | 4% | 4% | 4% |
| USA | 9% | 8% | 8% | 8% | 9% |
| Sweden | 7% | 8% | 10% | 10% | 10% |
| Other | 9% | 8% | 9% | 9% | 9% |
For more information about the ABGSC share and its largest shareholders, please visit the Investor Relations section on the ABGSC website (www.abgsc.com).


The Board currently has a mandate from the shareholders to acquire a number of ABGSC shares corresponding to approximately 10% of the share capital. The one-year mandate is valid until the end of June 2025.
| Expiry year |
Forward (1 000) contracts , |
Forward price average |
|---|---|---|
| 2025 | 500 | 1 91 |
| 2026 | 12 209 , |
5 62 |
| 2027 | 10 935 , |
6 41 |
| 2028 | 13 745 , |
5 51 |
| 2029 | 16 135 , |
6 49 |
| Total | 53 524 , |
As part of the partner share incentive programme, several partners in the firm have entered into forward contracts for the future delivery of shares. Under the programme, new and certain existing partners are given the opportunity to acquire restricted partner shares at market price, with a 15% price adjustment reflecting several restrictions with regards to the selling (or purchasing) of these shares.
The forward settlement price is adjusted for changes in interest rates and any cash distribution paid to shareholders. The interest element in the forward contract will also be adjusted in cases where the contract is settled prior to the original expiry date.
Cash distribution to shareholders (per share) Pay-out ratio (DPS/Diluted EPS)

▪ The Board is committed to returning excess capital to shareholders through cash and buy-backs of shares over time. Excess capital will be evaluated on a continuous basis, taking into consideration a number of factors, including market conditions, regulatory requirements, counterparty and market perceptions and the nature of our business


▪ ABGSC is well capitalised with a core capital ratio of 1.7x the current regulatory minimum requirement and 2.4x the expected future requirement

| Income statement | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| NOKm | Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
| Revenues | 303 | 508 | 426 | 379 | 356 | 545 | 403 | 510 | 392 |
| Operating costs |
-269 | -383 | -338 | -323 | -305 | -416 | -331 | -390 | -329 |
| Operating profit |
34 | 125 | 88 | 56 | 51 | 130 | 72 | 120 | 64 |
| Net financial result |
-7 | 4 | -1 | -5 | -1 | 1 | 4 | -2 | -3 |
| Profit before tax |
27 | 129 | 87 | 51 | 51 | 131 | 75 | 118 | 60 |
| Taxes | -9 | -31 | -22 | -12 | -15 | -33 | -19 | -30 | -15 |
| Non-controlling interests |
-2 | -5 | -1 | 0 | -1 | 0 | 2 | -1 | 0 |
| profit Net |
16 | 93 | 65 | 39 | 35 | 98 | 58 | 87 | 45 |
| Balance sheet | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| NOKm | Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
| Total non-current assets |
752 | 780 | 803 | 770 | 736 | 714 | 705 | 679 | 664 |
| Receivables | 4,931 | 2,242 | 4,903 | 5,352 | 3,098 | 2,670 | 3,656 | 6,370 | 4,757 |
| Investments | 95 | 63 | 75 | 70 | 53 | 14 | 73 | 76 | 36 |
| Cash and bank deposits |
922 | 832 | 799 | 571 | 620 | 526 | 775 | 542 | 533 |
| Total current assets |
5,948 | 3,137 | 5,778 | 5,993 | 3,770 | 3,210 | 4,503 | 6,988 | 5,326 |
| Total assets |
6,700 | 3,917 | 6,580 | 6,763 | 4,506 | 3,923 | 5,208 | 7,667 | 5,989 |
| Equity attributable to owners of the parent |
933 | 1,019 | 1,039 | 851 | 859 | 960 | 1,051 | 875 | 923 |
| Non-controlling interests |
3 | 8 | 11 | 11 | 12 | 12 | 10 | 11 | 12 |
| Total equity |
936 | 1,027 | 1,051 | 862 | 871 | 971 | 1,061 | 886 | 934 |
| Long-term liabilities |
476 | 480 | 497 | 488 | 479 | 433 | 441 | 433 | 426 |
| Short-term interest bearing liabilities |
49 | 70 | 163 | 237 | 332 | 3 | 169 | 325 | 169 |
| Short-term liabilities |
5,238 | 2,340 | 4,869 | 5,177 | 2,823 | 2,516 | 3,538 | 6,023 | 4,460 |
| liabilities Total |
5,764 | 2,890 | 5,530 | 5,901 | 3,635 | 2,952 | 4,147 | 6,781 | 5,055 |
| Total equity and liabilities |
6,700 | 3,917 | 6,580 | 6,763 | 4,506 | 3,923 | 5,208 | 7,667 | 5,989 |
| Segment revenues | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| NOKm | Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
| Corporate Financing |
62 | 124 | 182 | 132 | 122 | 144 | 122 | 247 | 161 |
| M&A and Advisory |
121 | 232 | 78 | 100 | 125 | 259 | 128 | 128 | 107 |
| Brokerage and Research |
120 | 152 | 166 | 147 | 110 | 143 | 153 | 135 | 124 |
| Group | 303 | 508 | 426 | 379 | 356 | 545 | 403 | 510 | 392 |
| NOKm | Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Norway | 190 | 266 | 209 | 195 | 153 | 388 | 214 | 256 | 239 |
| Sweden | 74 | 167 | 144 | 133 | 108 | 110 | 144 | 195 | 114 |
| Denmark | 18 | 38 | 15 | 11 | 65 | 11 | 5 | 20 | 7 |
| International | 21 | 37 | 58 | 39 | 30 | 37 | 39 | 40 | 32 |
| Group | 303 | 508 | 426 | 379 | 356 | 545 | 403 | 510 | 392 |

| Key figures | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| NOK | Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
| (average) Headcount |
336 | 341 | 341 | 343 | 346 | 338 | 333 | 331 | 335 |
| Revenues per head (average) |
0 90 |
1 49 |
1 25 |
1 10 |
1 03 |
1 62 |
1 21 |
1 54 |
1 17 |
| Operating per head (average) costs |
-0 80 |
-1 12 |
-0 99 |
-0 94 |
-0 88 |
-1 23 |
-0 99 |
-1 18 |
-0 98 |
| Operating / Revenues cost |
89% | 75% | 79% | 85% | 86% | 76% | 82% | 76% | 84% |
| Total compensation / Revenues |
60% | 56% | 57% | 59% | 60% | 57% | 57% | 56% | 59% |
| Operating margin % |
11% | 25% | 21% | 15% | 14% | 24% | 18% | 24% | 16% |
| (annualised) Return on Equity |
7% | 25% | 25% | 16% | 16% | 25% | 23% | 36% | 31% |
| Shares outstanding (period end) |
483 343 , |
483 343 , |
497 463 , |
497 463 , |
497 463 , |
497 463 , |
527 735 , |
527 735 , |
527 735 , |
| (period end) Treasury shares |
-6 419 , |
-5 669 , |
-13 401 , |
-5 586 , |
-9 549 , |
-8 649 , |
-7 109 , |
-7 159 , |
-7 059 , |
| Forward outstanding (period end) contracts |
80 726 , |
81 776 , |
76 176 , |
69 261 , |
69 486 , |
68 586 , |
52 999 , |
53 249 , |
53 524 , |
| Diluted shares (period end) |
557 650 , |
559 450 , |
560 238 , |
561 138 , |
557 399 , |
557 399 , |
573 624 , |
573 824 , |
574 199 , |
| (basic) Earnings per share |
0 03 |
0 19 |
0 14 |
0 08 |
0 07 |
0 20 |
0 12 |
0 17 |
0 09 |
| Earnings share (diluted) per |
0 03 |
0 17 |
0 12 |
0 07 |
0 07 |
0 18 |
0 11 |
0 16 |
0 09 |
| Book value per share (basic) |
1 96 |
2 13 |
2 15 |
1 73 |
1 76 |
1 96 |
2 02 |
1 68 |
1 77 |
| (diluted) Book value per share |
2 05 |
2 21 |
2 33 |
1 90 |
1 94 |
2 12 |
2 33 |
1 98 |
2 08 |
| Total capital adequacy |
4 683 , |
5 006 , |
4 966 , |
5 169 , |
4 937 , |
4 853 , |
5 046 , |
4 915 , |
4 816 , |
| Core capital |
627 | 671 | 614 | 643 | 621 | 623 | 632 | 633 | 636 |
| Total capital adequacy ratio |
13% | 13% | 12% | 12% | 13% | 13% | 13% | 13% | 13% |
| Minimum requirement coverage ratio |
1 7x |
1 7x |
1 5x |
1 6x |
1 6x |
1 6x |
1 6x |
1 6x |
1 7x |
13 February 2025 | Q4 2024 earnings release

ABG Sundal Collier ASA Pb. 1444 Vika Ruseløkkveien 26 8th floor NO-0251 Oslo
Tel +47 22 01 60 00
ABG Sundal Collier AB Regeringsgatan 25 8th floor SE-11153 Stockholm Tel +46 8 566 286 00
ABG Sundal Collier Ltd. St Martin's Court 25 Newgate St 5th floor UK-EC4M 7EJ London Tel +44 207 905 5600
ABG Sundal Collier ASA Copenhagen Branch Forbindelsesvej 12 DK-2100 Copenhagen Ø
Tel +45 3546 3000
ABG Sundal Collier ASA Frankfurt Branch Schillerstrasse 2 5. Obergeschoss DE-60313 Frankfurt /Main
Tel +49 69 96 86 96 0
ABG Sundal Collier Inc. 140 Broadway Suite 4604 US-10005 New York Tel +1 212 605 3800
ABG Sundal Collier Pte Ltd 10 Collyer Quay Ocean Financial Center #40-07, Singapore 049315
Tel +65 6808 6082
ABG Sundal Collier AG Representative Office Schwanenplatz 4 6004 Lucerne
Tel +41 79 502 33 39
This material is for distribution only under such circumstances as may be permitted by applicable law. It has no regard to the specific investment objectives, financial situation or particular needs of any recipient. It is published solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. No representation or warranty, either expressed or implied, is provided in relation to the accuracy, completeness or reliability of the information contained herein, nor is it intended to be a complete statement or summary of the securities, markets or developments referred to in the materials. It should not be regarded by recipients as a substitute for the exercise of their own judgement. Any opinions expressed in this material are subject to change without notice and may differ or be contrary to opinions expressed by other business areas or groups of ABGSC as a result of using different assumptions and criteria. ABGSC is under no obligation to update or keep current the information contained herein. ABGSC, its directors, officers and employees' or clients may have or have had interests or long or short positions in the securities or other financial instruments referred to herein and may at any time make purchases and/or sales in them as principal or agent. ABGSC may act or have acted as market-maker in the securities or other financial instruments discussed in this material. Furthermore, ABGSC may have or have had a relationship with or may provide or has provided investment banking, capital markets and/or other financial services to the relevant companies. Neither ABGSC nor any of its affiliates, nor any of ABGSC' or any of its affiliates, directors, employees or agents accepts any liability for any loss or damage arising out of the use of all or any part of this material.
© 2024 ABG Sundal Collier ASA. All rights reserved. ABG Sundal Collier ASA specifically prohibits the redistribution of this material and accepts no liability whatsoever for the actions of third parties in this respect.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.